This Innovaccer company profile covers the company's valuation, revenue, funding rounds, investors and history. Innovaccer works in healthcare, with a focus on healthcare data platform and AI. It was founded in 2014 and is headquartered in San Francisco, California, United States. Its latest valuation on record is About US$3.45 billion (reported) (January 2025). Every figure links to a public source, and anything the company hasn't disclosed is marked as such.
Revenue
| Metric | Value | As of | Source |
|---|---|---|---|
| Total funding | About US$675 million | January 2025 | Fierce Healthcare |
Funding history
| Date | Round | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jan 2025 | Series F | US$275M | About US$3.45B (reported) | B Capital, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente, M12 | Fierce Healthcare |
| Dec 2021 | Series E | US$150M | US$3.2B | Tiger Global (lead) | Fierce Healthcare |
Innovaccer timeline
Key dates from the sources on this page, oldest first. Metric snapshots are listed after the funding events.
- 2014 — Innovaccer is founded in San Francisco by Abhinav Shashank (CEO), Kanav Hasija and Sandeep Gupta.
- Dec 2021 — Series E: US$150M, valuing the company at US$3.2B. Investors: Tiger Global (lead).
- Jan 2025 — Series F: US$275M, valuing the company at About US$3.45B (reported). Investors: B Capital, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente, M12.
- January 2025 — Total funding: About US$675 million.
Investors
Overview
Innovaccer builds a healthcare data platform that brings together patient information scattered across electronic health records, insurance claims, labs, pharmacies and other systems, creating a unified view of each patient and population. Health systems, physician groups and insurers use it for population health management, value-based care contracts, care coordination, analytics and, increasingly, AI agents that automate administrative and clinical support tasks. Innovaccer describes its mission as unifying healthcare data to improve outcomes and reduce costs.
Abhinav Shashank, the CEO, Kanav Hasija and Sandeep Gupta founded Innovaccer in 2014. The founders studied in India, and the company began with data and analytics work before focusing on US healthcare. Innovaccer is headquartered in San Francisco with large engineering teams in India, particularly in Noida, and is often counted among India's healthtech unicorns.
Products
- Healthcare data platform: integration and normalisation of data from hundreds of sources into a single patient record.
- Population health management: tools to identify patients at risk, close care gaps and manage chronic conditions.
- Value-based care analytics: tracking quality measures and financial performance under risk-based contracts.
- Care management: workflows for care coordinators and nurses.
- AI agents: assistants that handle tasks such as scheduling, referral management, prior authorisation support, documentation and patient outreach.
- Patient engagement and CRM: communication tools and patient access solutions.
Funding
Innovaccer raised from investors including Tiger Global, Steadview Capital, B Capital, Mubadala and M12 (Microsoft's venture fund). In December 2021 it raised a US$150 million Series E at a US$3.2 billion valuation, led by Tiger Global. In January 2025 it raised a US$275 million Series F, combining primary and secondary investment, with participation from B Capital, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente and M12. The company didn't disclose the valuation; a source familiar with the deal told Fierce Healthcare the post-money valuation of the primary funding was about US$3.45 billion, so we label it as reported. Total funding reached about US$675 million.
Business model
Innovaccer sells enterprise subscriptions to health systems, accountable care organisations, physician groups, insurers and government health agencies, typically priced by population size and modules. Health system investors such as Banner Health and Kaiser Permanente are also strategic partners. The company doesn't publish revenue, so we show it as not disclosed.
Competition
Innovaccer competes with electronic health record vendors such as Epic and Oracle Health, which offer population health tools; with healthcare analytics companies such as Arcadia, Health Catalyst and Innovaccer's peers in value-based care; and with AI companies such as Abridge and Hippocratic AI in specific workflows. Its advantages are its data integration capabilities across many systems and its broad platform.
Innovaccer at a glance
Innovaccer is a San Francisco healthcare data and AI company founded in 2014 by Abhinav Shashank, Kanav Hasija and Sandeep Gupta, with large engineering teams in India. It unifies patient data and offers population health, analytics and AI agents. It raised a US$150 million Series E at US$3.2 billion in 2021 and a US$275 million Series F in January 2025 at a reported valuation of about US$3.45 billion.
Timeline
- 2014: founded.
- 2017–2020: focuses on US healthcare data and population health; raises growth funding.
- 2021: becomes a unicorn and raises at US$3.2 billion.
- 2024: launches AI agents for healthcare workflows.
- January 2025: raises US$275 million at a reported US$3.45 billion.
Why healthcare data is fragmented
A patient in the US may see several doctors using different EHR systems, visit hospitals in different networks, fill prescriptions at multiple pharmacies and have claims processed by insurers. Each system holds part of the story, in different formats. Without a unified view, clinicians miss information, care gaps go unnoticed and organisations struggle to manage costs under value-based contracts, which reward keeping populations healthy. Data platforms that integrate these sources are a foundation for analytics and AI in healthcare.
Value-based care
In value-based care, providers are paid for outcomes and cost control rather than the volume of services. Medicare programmes and many insurers use such contracts. Success requires knowing which patients need attention, coordinating care and tracking quality measures, all of which depend on good data. The shift towards value-based care has been gradual but continues to drive demand for population health platforms.
Who uses Innovaccer
Innovaccer's customers include health systems, physician networks, accountable care organisations, insurers and public health agencies in the United States.
Risks
- EHR competition: Epic and others bundle similar tools.
- Healthcare budgets: hospital finances affect software spending.
- Valuation disclosure: the latest valuation is reported, not confirmed.
AI agents in healthcare administration
US healthcare involves enormous administrative work: scheduling appointments, managing referrals, checking insurance eligibility, preparing prior authorisation requests and following up with patients. Much of this is repetitive and handled by staff on phones and computers. Innovaccer's AI agents aim to automate parts of these workflows using its unified data, reducing costs and delays. Health systems facing staff shortages are interested, but they demand accuracy and clear oversight.
Valuation context
Innovaccer's reported valuation rose only modestly from US$3.2 billion in 2021 to about US$3.45 billion in 2025, reflecting the reset in healthcare technology valuations, even as it expanded its AI offerings.
Questions for health systems
- Which data sources and EHRs can the platform integrate?
- How are AI agents supervised, and how are errors caught?
- What measurable outcomes have similar organisations achieved?
Its India-based engineering teams give it a cost advantage in building and maintaining complex integrations.
Latest developments (October 2026)
Our October 2026 review found no new primary round for Innovaccer after its January 2025 Series F of US$275 million at about US$3.45 billion. Secondary-market estimates in 2026 were well below that figure, though trading is thin. The company continues to sell AI tools for healthcare data, population health and care management to US health systems. See our healthcare AI guide.
What to watch
Watch AI agent adoption, health system partnerships, any IPO plans and competition from EHR vendors. Our guide to healthcare AI startups covers related companies.
Takeaways
Health systems and payers can unify data to manage populations and automate work. Founders can see how India-US teams build global healthcare software. Investors should note the valuation is a reported figure.
Sources
Every figure on this page comes from the public sources below. Where sources disagreed, we used the company's own announcement or a primary news report. Private-company data changes; check the date beside each figure.
Frequently asked questions
What does Innovaccer do?
Innovaccer is a healthcare / healthcare data platform and ai company headquartered in San Francisco, California, United States. It was founded in 2014.
What is Innovaccer's valuation?
Innovaccer was valued at About US$3.45 billion (reported) as of January 2025, according to Fierce Healthcare. Private company valuations are set at funding rounds or share sales and can change significantly between them.
How much revenue does Innovaccer make?
Innovaccer is a private company and has not publicly disclosed its revenue. Figures on third-party sites are usually modelled estimates rather than numbers reported by the company.
What was Innovaccer's latest funding round?
The most recent financing we have verified is a series f in Jan 2025: US$275M, at a valuation of About US$3.45B (reported). Source: Fierce Healthcare.
Who are Innovaccer's investors?
Investors named in public announcements include B Capital, Banner Health, Danaher Ventures, Generation Investment Management, Kaiser Permanente, M12, Tiger Global, Steadview Capital and Mubadala.
Who founded Innovaccer?
Innovaccer was founded in 2014 by Abhinav Shashank (CEO), Kanav Hasija and Sandeep Gupta.
Is Innovaccer a public company?
No. Innovaccer is a private company (private, venture backed), so its shares are not traded on a stock exchange and it isn't required to publish its financial results.
Where is Innovaccer headquartered?
Innovaccer is headquartered in San Francisco, California, United States.